ECCRT and IDDI Partner for Continuous Development
ECCRT and IDDI have established a partnership for the continuous development of IDDI global team members.
The European Centre for Clinical Research Training (ECCRT) and the International Drug Development Institute (IDDI) have established a partnership for the continuous development of IDDI global team members.
Announced in a Sept. 9, 2020 press release, the partnership will see ECCRT providing access to the eLearning ‘Virtual Campus’ platform that will enable IDDI’s members to attend training sessions on the International Council for Harmonization good clinical practice and other related topics.
“Good clinical practice (GCP) guidelines and their role in clinical trials [are] key to IDDI’s business,” said Damien Tremolet, CEO of IDDI, in the press release.“ECCRT training services offering precisely matches our needs: online, short, and focused learning combined with workshop training for our global team. It will allow our staff to develop and improve the GCP skills that are essential to ensure the quality, reliability, and integrity of our sponsor’s clinical data.
Benedikt Van Nieuwenhove, managing director of ECCRT, added, in the press release, “We are very pleased to enable IDDI to have all their staff trained to the latest standards, and to allow IDDI to implement employee learning and development on a strategic level.”
Source: IDDI
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
